We aimed at estimating the agreement between the Medicap® (photo-optical) and Radiometer® (electrochemical) sensors during exercise transcutaneous oxygen pressure (tcpO 2 ) tests. Our hypothesis was that although absolute starting values (tcpO 2 rest: mean over 2 minutes) might be diff erent, tcpO 2 -changes over time and the minimal value of the decrease from rest of oxygen pressure (DROPmin) results at exercise shall be concordant between the two systems. Patients and methods: Forty seven patients with arterial claudication (65 + / -7 years) performed a treadmill test with 5 probes each of the electro-chemical and photo-optical devices simultaneously, one of each system on the chest, on each buttock and on each calf. Results: Seventeen Medicap® probes disconnected during the tests. tcpO 2 rest and DROPmin values were higher with Medicap® than with Radiometer®, by 13.7 + / -17.1 mm Hg and 3.4 + / -11.7 mm Hg, respectively. Despite the diff erences in absolute starting values, changes over time were similar between the two systems. Th e concordance between the two systems was approximately 70 % for classifi cation of test results from DROPmin. Conclusions: Photo-optical sensors are promising alternatives to electro-chemical sensors for exercise oximetry, provided that miniaturisation and weight reduction of the new sensors are possible.
Introduction
Claudication is defi ned as pain or discomfort in the legs, thighs or buttocks that is worsened by exercise and relieved with rest. It is one of the symptoms of lower extremity peripheral artery disease, but can also occur in patients who have non-vascular problems. In addition to classical tools, the recording of transcutaneous oxygen pressure (tcpO 2 ) during exercise is useful in selected patients with atypical claudication or claudication of questionable vascular origin [1 -3] . Transcutaneous oximetry (tcpO 2 ) is based on the measurement of the quantity of oxygen that diffuses through the tissue to the skin surface. Th erefore, a transcutaneous gradient exists that results in the surface tcpO 2 being lower than the arterial underlying oxygen pressure. Th is gradient is unpredictable and may vary from one probe position to another, resulting in a relatively wide variability of absolute values when two probes are positioned close to one another. An interesting point is that once the probe is in position, the absolute changes observed with transcutaneous oximetry mimic the changes of arterial pO2 provided that the latter changes are relatively slow [4, 5] . Th erefore, transcutaneous oximetry at the chest level was proposed as a way of monitoring arterial pO2 in exercising subjects [4, 6] . Beyond the use of tcpO 2 to evaluate critical limb ischaemia [7, 8] , exercise tcpO 2 can be used to monitor tcpO 2 changes during exercise in patients with claudication. By replacing the previously proposed regional perfusion index [9] , by an index that becomes independent from starting values (i. e.: DROP index), it was shown that exercise tcpO 2 accuracy and reliability was increased [10 -12] . It had previously been shown that exercise tcpO 2 using the DROP was specifi cally useful to confi rm the vascular origin of buttock claudication [10] . Th is DROP index is 85 % accurate and reliable to detect arteriographic lesions toward the hypogastric and limb circulation [10 -12] and allows additional diagnoses in patients with negative or non-contributive ultrasound imaging [1, 13] . Currently, the only tcpO 2 available sensor is produced by the Radiometer® company and used on various commercially available devices. Th is sensor is based on an electrochemical analysis of oxygen. Recently, the Medicap® company has launched a device to measure tcpO 2 at the skin level, with sensors using a photo-optical measuring principle, which has been extensively described elsewhere [14] . Both techniques claim to measure oxygen pressure. Th e potential advantages of the photochemical technique are that it is readily calibrated, the cleaning of the sensors is easy and does not require an expensive membrane change, and the fact that it is possible to connect up to 8 probes. Overall, the price of a 5-probe Medicap® system is much cheaper (30 -40,000€) than most available 5-probe devices (Perimed®, Radiometer®) that use electrochemical sensors (55 -65,000 €). Th e objective of this study was therefore to estimate the agreement between the Medicap® and Radiometer® devices for measuring tcpO 2 at rest and during exercise. Th e DROP index was proposed for exercise tests as a way of removing the transcutaneous
Patients and methods
Th is study was approved by the local Ethics Committee of Research. Over a two month period starting in June 2014, all new adult patients were proposed to participate if they were able to understand the study design, agreed to participate and signed a consent form. Written informed consent was obtained from all of the included patients.
Study population
Fift y three patients with symptoms of claudication were referred for exercise oximetry to the laboratory over the study period. Forty seven agreed to participate. Before each test, information recorded in our database included patient's history and characteristics (gender, age, body mass, stature, ongoing treatments, and ABI at rest on both legs). Usual walking speed was retrieved from a 10 m long walk in the laboratory corridor at the usual regular pace. Th e characteristics of the included patients are reported in Table I . As shown in Table I , patients were referred for claudication, not on the sole basis of a low ABI or abnormal ultrasound investigation, but also for proximal claudication or claudication of debated vascular origin when ABI is likely not to be the optimal technique for diagnosis [1] .
Measurements

Treadmill test
Th e treadmill speed and grade were increased from zero to 3.2 km . h -1 and from zero to 10 % within one minute. Th en, the speed was stabilised to 3.2 km . h -1 for a total of 15 minutes.
At minute 16, if the patient was still able to walk, the speed and grade were progressively increased by steps of 1 minute up to exhaustion or to limitation by symptoms, as previously reported [15] . Roughly one minute increments of this second phase resulted in grade and speed that were comparable to the Bruce protocol values every three minutes [15] . Patients were encouraged orally to perform the highest possible test duration. In all cases, exercise was stopped at the patient's request in case of claudication up to absolute walking distance (and not when pain fi rst occurs) or in the case of persistent severe arrhythmia, dyspnoea or dizziness. Recovery was recorded for 10 minutes in the standing position. Following each test, we recorded the maximal walking time on treadmill.
Methods for tcpO2 recordings
As a routine, aft er a 20 minute period at rest, patients were installed in a 21 + / -2 °C air-conditioned room. TcpO 2 measurements were performed using a 5-modules TCM400 (Radiometer®, Copenhagen, DK) and a 5-modules Précise 8008 (Medicap®, Ulrichstein, Germany). A one point calibration to air was performed before each experiment for both devices and repeated twice for the Radiometer® device. Th e calibration values were set according to actual barometric pressure. Th e temperature of all probes was 44.5 °C, to allow maximal local vasodilatation, thereby decreasing the arterial to skin pressure gradient. Th e tcpO 2 measurements were automatically temperature-corrected to 37 °C by the transcutaneous devices. As a standard, one probe of each device Th e advantage of the cross-correlation coeffi cient (CCC) is that it is independent from the starting value of each probe and may account for slight diff erences in the time response of the systems. Th e disadvantage of this approach is that the coeffi cient of cross-correlation will be low if few changes are observed during exercise on one or both probes (almost fl at curves). In the case of probe disconnection during the test, the CCC was not calculated.
Th ird, the decrease from rest of oxygen pressure (DROP) was calculated as previously described as the absolute change from rest of limb probe minus the absolute change from rest at the chest level. By construction, the DROP is zero (or close to zero) throughout the rest period, decreases during exercise in the case of regional blood fl ow impairment (RBFI) and returns to zero within 10 minutes in the recovery from exercise. A small drift may occur during the recording on tcpO2 probes resulting in the last DROP value (DROP fi nal ) observed at the time of the end of exercise (T fi nal ) being slightly diff erent from zero. Th is drift can be rectifi ed to obtain a drift -corrected DROP (DROP*) by correcting each DROP value at time "T" by the following formula: DROP* = DROP + T • (DROP fi nal ) / T fi nal . Th e minimal DROP and DROP* values (DROP min ) and DROP* min were kept for the analysis. DROP min or DROP* min are expected to be zero (or close to zero) in the absence of RBFI. Th e lower DROP min or DROP* min values correspond to the more severe RBFI. Th e previously validated normal limit for DROP to detect arteriographically proved lesions at the leg and buttock level is minus 15 mm Hg. Th e advantage of the DROP index is that it is independent from the absolute starting value and only accounts for absolute changes over time. In the case of probe disconnection during the test, the DROP min and DROP* min were not calculated. Fourth, we compared the concordance of result classifi cation obtained with the Medicap® device using different arbitrarily fi xed thresholds to the results observed with the Radiometer® device using the previously validated (-15 mm Hg) threshold [10 -12, 16] . 
Statistical analyses
Results
All but one patient were able to walk at 3.2 km / h and 10 % slope for a minimum of 30 seconds. Th e average walking duration on treadmill was 402 + / -343 sec. In total, 41 (87 %) of the patients reported lower limb pain and 15 patients complained of nonlimb symptoms such as dyspnoea (n = 13), fatigue (n = 2) or dizziness (n = 1). Heart rate at the end of exercise was 119 + / -22 beats per min. We observed no probe disconnection with the radiometer device throughout the recordings, whereas eleven Medicap® probes disconnected during the two minute rest period; of these, two probes were at chest level. Medicap®) of probes in close proximity. As a result, more than half of the CCC results were equal or superior to 0.80, as shown in Figure 3 . Many of the CCC results that were close to zero or even negative (inverse relationship between the two probes in close proximity) relied on probes with very small changes over time (e. g.: stability over time with minimal changes around the starting value DROPmin, left leg DROPmin, right buttock DROPmin, right leg DROPmin, left buttock DROP*min, left leg DROP*min, right buttock DROP*min and right leg DROP*min, respectively. As shown in Table II , when comparing pairs of available data, since the DROP index is largely independent of the starting value, it is not surprising that despite the large and signifi cant diff erences observed in Figure 1 , the diff erences in calculated DROP min and DROP* min were reduced and oft en did not reach statistical signifi cance.
Results for all probe positions are presented in Figure 2 . It is of interest to note that, on average, the DROP min or DROP* min were higher (smaller decrease during exercise) with Medicap® than with Radiometer® by 3.4 + / -11.7 mm Hg and by 4.3 + / -10.0 mm Hg, respectively (both p < 0.01; n = 162). Th e mean of absolute diff erences of all available pairs of recordings (n = 162) was 9.4 + / -9.2 mm Hg for DROP min and 8.0 + / -8.4 mm Hg for DROP* min . Overall, the correlation between the two devices was higher for DROP min and DROP* min than for absolute values. Finally, when interpretation of the DROP min and DROP* min was performed using the -15 mm Hg standard value for Radiometer® and different cut-off values for Medicap®, we found a concordance of approximately 70 % for DROP min and 75 to 80 % for DROP* min , as shown in Figure 4 . It is interesting to note that the best concordance for DROP* min was observed for a cut-off value of minus 11 mm Hg for the Medicap®, which is consistent with the fact that DROP* min values observed on Medicap® probes were higher compared to those observed on the Radiometer® probes.
Discussion
Th is is the fi rst report of the use of the Medicap® system in a clinical routine for exercise oximetry. Our results show a reasonable concordance of the tcpO 2 -changes observed with new photo-optical sensors with those found with the classical electrochemical sensors, at least during exercise. Nevertheless, there seems to be a trend for higher absolute values with the Medicap® than with the Radiometer® sensors.
Our results confi rm that changes over time (as estimated through the CCC) are comparable with the two sensors in most cases. Notably, the Medicap® sensors seem to provide smoother curves. Th is does not seem to result in a slower half time response of the Medicap® sensors, since we tested the two systems in a gas chamber with abrupt pO 2 changes and their half time response was comparable (data not shown). It is possible that this smoothed appearance explains the reduced changes observed with Medicap® compared to Radiometer® but whether electrochemical sensors on a Perimed® device would have provided comparable results was not studied in our experiment. Th is is one of the limits of the present study. Additional data are needed to check whether higher absolute tcpO2 values would also be observed with Medicap® sensors than with Radiometer® ones, in patients with critical limb ischaemia (and resting limb values in a low range). Th is diff erence might rely on the consumption of oxygen by electrochemical but not photo-optical probes. If a diff erence was also observed, the use of the new technique would require that the limits proposed for the interpretation of tcpO 2 at rest with electrochemical sensor for wound healing or critical limb ischaemia would be adapted for the new photo-optical sensors. It clearly seems necessary to defi ne a specifi c normal limit at exercise with the Medicap® device, when the normal limit used is probably higher than -15 mm Hg, as suggested in Figure 4 . Unfortunately, the number of available arterial images in our population did not allow a direct validation of the Medicap® DROP results versus imaging.
A signifi cant issue that we faced with the Medicap® system was a high rate of probe disconnecting from the skin during the tests. Th is could result from our team being experienced with radiometer® devices and not with Medicap® ones, although the probe holders are the same. We think that this high rate of disconnection relies on the weight of the sensor head and stiff ness of the optic fi bre cable compared to the electric fi bre of electrochemical probes. Nets around the limb might help to stabilise the probes, and we expect that the manufacturer might miniaturise this new system in the future. Among others, one of the limits of this work is that we tested a relatively small number of patients in a single centre trial. Finally, on the one hand, exercise tcpO 2 remains a time-consuming technique and is unlikely to replace other non-invasive (ultrasound) approaches in the future. Nevertheless, it can help to diagnose patients with atypical claudication or claudication of doubtful vascular origins [1 -3, 17] and is presently spreading in France [18] and abroad [19] . On the other hand, we do not report the data for invasive radiological investigations here since radio-vascular investigations were not systematically performed and overall because the exercise-tcpO 2 technique itself has been largely validated in the past [10 -12, 16, 20 , 21]. 
Conclusions
Th is study confi rms that, at least for exercise tests, the photo-optical technology provides a promising alternative to the devices using electro-chemical sensors, provided that future validation studies confi rm our results and that miniaturisation of the new sensors is possible. Additional studies are required in situations of critical limb ischaemia, specifi cally to confi rm or not the trend observed here for higher absolute values with the photo-optical sensors than with electrochemical ones. 
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